GB1550399A - Prostane derivatives - Google Patents

Prostane derivatives

Info

Publication number
GB1550399A
GB1550399A GB51196/76A GB5119676A GB1550399A GB 1550399 A GB1550399 A GB 1550399A GB 51196/76 A GB51196/76 A GB 51196/76A GB 5119676 A GB5119676 A GB 5119676A GB 1550399 A GB1550399 A GB 1550399A
Authority
GB
United Kingdom
Prior art keywords
prostane derivatives
prostane
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB51196/76A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Priority to GB51196/76A priority Critical patent/GB1550399A/en
Priority to IE2409/77A priority patent/IE46170B1/en
Priority to ZA00777059A priority patent/ZA777059B/xx
Priority to CA000291953A priority patent/CA1119591A/en
Priority to AU31044/77A priority patent/AU3104477A/en
Priority to NZ185822A priority patent/NZ185822A/xx
Priority to IT30508/77A priority patent/IT1089433B/it
Priority to SE7713895A priority patent/SE7713895L/xx
Priority to FR7736892A priority patent/FR2373538A1/fr
Priority to DK548177A priority patent/DK548177A/da
Priority to BE183294A priority patent/BE861652A/xx
Priority to DE19772754741 priority patent/DE2754741A1/de
Priority to NL7713587A priority patent/NL7713587A/xx
Priority to JP14772977A priority patent/JPS5371060A/ja
Publication of GB1550399A publication Critical patent/GB1550399A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/02—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D305/04—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D305/08—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/02—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D305/04—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D305/06—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D331/00—Heterocyclic compounds containing rings of less than five members, having one sulfur atom as the only ring hetero atom
    • C07D331/04—Four-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/65515—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring
    • C07F9/65517—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring condensed with carbocyclic rings or carbocyclic ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Steroid Compounds (AREA)
GB51196/76A 1976-12-08 1976-12-08 Prostane derivatives Expired GB1550399A (en)

Priority Applications (14)

Application Number Priority Date Filing Date Title
GB51196/76A GB1550399A (en) 1976-12-08 1976-12-08 Prostane derivatives
IE2409/77A IE46170B1 (en) 1976-12-08 1977-11-28 Prostane derivatives
ZA00777059A ZA777059B (en) 1976-12-08 1977-11-28 Prostane derivatives
CA000291953A CA1119591A (en) 1976-12-08 1977-11-29 Prostane derivatives
AU31044/77A AU3104477A (en) 1976-12-08 1977-11-29 Pharmaceutical or veterinary oxetan, thietan, tetrahydrofuranand tetrahydrothiophen derivatives of prostane
NZ185822A NZ185822A (en) 1976-12-08 1977-11-30 Prostane derivatives and pharmaceutical compositions
IT30508/77A IT1089433B (it) 1976-12-08 1977-12-06 Derivati del prostano
SE7713895A SE7713895L (sv) 1976-12-08 1977-12-07 Sett att framstella prostansyraderivat
FR7736892A FR2373538A1 (fr) 1976-12-08 1977-12-07 Nouveaux derives de prostane, leur procede de preparation et medicament les contenant
DK548177A DK548177A (da) 1976-12-08 1977-12-08 Prostanderivater
BE183294A BE861652A (fr) 1976-12-08 1977-12-08 Derives de prostane
DE19772754741 DE2754741A1 (de) 1976-12-08 1977-12-08 Prostanderivate
NL7713587A NL7713587A (nl) 1976-12-08 1977-12-08 Werkwijze voor de bereiding van prostaanderi- vaten.
JP14772977A JPS5371060A (en) 1976-12-08 1977-12-08 Prostane derivative process for preparing same medicine containing same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB51196/76A GB1550399A (en) 1976-12-08 1976-12-08 Prostane derivatives

Publications (1)

Publication Number Publication Date
GB1550399A true GB1550399A (en) 1979-08-15

Family

ID=10459023

Family Applications (1)

Application Number Title Priority Date Filing Date
GB51196/76A Expired GB1550399A (en) 1976-12-08 1976-12-08 Prostane derivatives

Country Status (14)

Country Link
JP (1) JPS5371060A (enExample)
AU (1) AU3104477A (enExample)
BE (1) BE861652A (enExample)
CA (1) CA1119591A (enExample)
DE (1) DE2754741A1 (enExample)
DK (1) DK548177A (enExample)
FR (1) FR2373538A1 (enExample)
GB (1) GB1550399A (enExample)
IE (1) IE46170B1 (enExample)
IT (1) IT1089433B (enExample)
NL (1) NL7713587A (enExample)
NZ (1) NZ185822A (enExample)
SE (1) SE7713895L (enExample)
ZA (1) ZA777059B (enExample)

Also Published As

Publication number Publication date
AU3104477A (en) 1979-06-07
ZA777059B (en) 1978-08-30
FR2373538B1 (enExample) 1981-07-10
CA1119591A (en) 1982-03-09
JPS5371060A (en) 1978-06-24
BE861652A (fr) 1978-06-08
IE46170B1 (en) 1983-03-09
SE7713895L (sv) 1978-06-09
NL7713587A (nl) 1978-06-12
DK548177A (da) 1978-06-09
DE2754741A1 (de) 1978-06-15
IE46170L (en) 1978-06-08
FR2373538A1 (fr) 1978-07-07
NZ185822A (en) 1979-03-16
IT1089433B (it) 1985-06-18

Similar Documents

Publication Publication Date Title
NZ183050A (en) Prostaglandin derivatives
PH15041A (en) 4-hydroxyphenylalkanolamine derivatives
IL52002A0 (en) M-phenoxybenzamide derivatives
GB1541547A (en) 4-phenoxymethylpiperidine derivatives
GB1521020A (en) 4-hydrox-aporphine derivatives
GB1538842A (en) Prostaglandin derivatives
AU2222977A (en) Tetrahydro-echinocandin b derivatives
JPS52113947A (en) Prostaglandin derivatives
GB1543124A (en) 2-iminothiazolidine derivatives
GB1554517A (en) Nogarol derivatives
GB1539268A (en) Prostane derivatives
JPS52105138A (en) Novellphenyll22aminoethanol derivatives
GB1553759A (en) Tetrahyddropyridine derivatives
ZA774279B (en) Prostane derivatives
GB1549755A (en) N-4-halobutyryl derivatives
GB1523198A (en) Thiazolo-rifamycin derivatives
GB1524481A (en) Tetrahydo - imidazopyridine derivatives
IL52270A0 (en) Hydrazinopyridazine derivatives
GB1545021A (en) 5-norbicyclomycin derivatives
JPS52100431A (en) Anilinoacetate derivatives
GB1550399A (en) Prostane derivatives
AU2536577A (en) 2-nitroindandione derivatives
AU2680877A (en) Arylaminopyrimidine derivatives
JPS52105159A (en) Estrogene derivatives
GB1535080A (en) Naphthacenequinone derivatives

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee